Aetna price target raised to $72 from $67 at Susquehanna Susquehanna raised its price target on Aetna following the closing of its acquisition of Coventry Health as management anticipates earnings accretion to double over the next couple of years. Near-term the firm believes the company is well positioned to exceed its 2013 guidance. Shares are Positive rated.
Subscribe for More Information
